A review of drug therapy for neonatal hypertension

Michele J. Beaulieu, Christina Carsello

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Neonatal hypertension is becoming a more common diagnosis because of higher survival rates in premature infants and the need for intravascular access and invasive blood pressure (BP) monitoring. Defining hypertension in the neonatal population has been challenging, and understanding what constitutes a normal BP is still evolving. Five general classes of antihypertensives exist for the treatment of hypertension in neonates. Few studies are available to guide clinicians in the treatment of hypertension in neonates, and limited data exist regarding outcomes of hypertension in the neonatal period.

Original languageEnglish (US)
Pages (from-to)95-100
Number of pages6
JournalNeonatal Network
Issue number2
StatePublished - 2014
Externally publishedYes


  • Angiotensin-converting enzyme inhibitors (ACEI)
  • Antihypertensives
  • Hypertension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'A review of drug therapy for neonatal hypertension'. Together they form a unique fingerprint.

Cite this